Evidence map›Paper›PMID 25597915›Full record

ArticleArchives of physical medicine and rehabilitation2015

Self-efficacy as a longitudinal predictor of perceived cognitive impairment in individuals with multiple sclerosis.

Abbey J Hughes, Meghan Beier, Narineh Hartoonian, Aaron P Turner, Dagmar Amtmann, Dawn M Ehde

Registry-linked trialAbstract read
In one paragraph

Article in Archives of physical medicine and rehabilitation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03782246 (Mindfulness-based Cognitive Therapy and Cognitive Behavioral Therapy for Chronic Pain in Multiple Sclerosis), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03782246 naunknown statusnot on this mapstarted 2018, after this paper: background citation

Mindfulness-based Cognitive Therapy and Cognitive Behavioral Therapy for Chronic Pain in Multiple Sclerosis

TypeinterventionalSponsorUniversity of WashingtonRan2018 to 2022Enrolled273ConditionsMultiple SclerosisArmsMBCT, CBT
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Relations among daily symptoms of depression.British journal of psychology (London, England : 1953) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Abbey J HughesDepartment of Rehabilitation Medicine, University of Washington, Seattle, WA; Multiple Sclerosis Center of Excellence West, Veterans Affairs Puget Sound Health Care System, Seattle, WA. Electronic address: ajhughes@uw.edu.
Meghan BeierDepartment of Rehabilitation Medicine, University of Washington, Seattle, WA.
Narineh HartoonianMultiple Sclerosis Center of Excellence West, Veterans Affairs Puget Sound Health Care System, Seattle, WA.
Aaron P TurnerDepartment of Rehabilitation Medicine, University of Washington, Seattle, WA; Multiple Sclerosis Center of Excellence West, Veterans Affairs Puget Sound Health Care System, Seattle, WA.
Dagmar AmtmannDepartment of Rehabilitation Medicine, University of Washington, Seattle, WA.
Dawn M EhdeDepartment of Rehabilitation Medicine, University of Washington, Seattle, WA.
University of Washington · USVA Puget Sound Health Care System · US

Funding

UW Center on Outcomes Research in Rehabilitation(RMI)U01AR052171 · NIAMS · UNIVERSITY OF WASHINGTON · PI AMTMANN, DAGMAR · 2004 to 2008
$5.0M
NIAMS NIH HHS 5U01AR052171-03NIAMS NIH HHS U01 AR052171
6 · The paper itself

Abstract

objectivesTo determine whether self-efficacy longitudinally predicts 2 types of perceived cognitive impairment (PCI) in multiple sclerosis (MS): general cognitive functioning and executive functioning; and secondarily to assess whether self-efficacy mediates the relationships between depression, fatigue, and PCI.

designLongitudinal analysis of self-report survey data collected over 3 years. Hierarchical regression analyses examined the relationship between self-efficacy and PCI, adjusting for depression and fatigue. Additional analyses tested self-efficacy as a mediator between depression, fatigue, and PCI.

settingCommunity.

participantsCommunity-dwelling individuals with MS (N=233; age range, 22-83y) were recruited from a larger longitudinal survey study of individuals with MS (N=562).

interventionsNot applicable.

main outcome measuresPrimary outcome measures were the Applied Cognition-General Concerns and the Applied Cognition-Executive Function domains of the Quality of Life in Neurological Disorders (NeuroQoL) measures.

resultsSelf-efficacy was significantly correlated with PCI at baseline (r=.40-.53) and 3 years later (r=.36-.44). In multivariate regression analyses, self-efficacy was a significant longitudinal predictor of PCI, both for general cognitive functioning (β=.20, P<.01) and executive functioning (β=.16, P<.05). Self-efficacy partially mediated the relationships between depression, fatigue, and PCI.

conclusionsSelf-efficacy may influence how individuals with MS perceive their cognitive functioning over time. Interventions that target self-efficacy, particularly early in the disease course, may lead to improvements in PCI, as well as improvements in fatigue and depression.

Indexed as

Self EfficacyAdaptation, PsychologicalAdultAgedAged, 80 and overCognition DisordersDepressionEducational StatusFatigueHumansLongitudinal StudiesMiddle AgedMultiple SclerosisNeuropsychological TestsQuality of LifeSeverity of Illness IndexCognitionExecutive functionLongitudinal studiesMultiple sclerosisRehabilitationSelf efficacySelf report

Identifiers

PMID25597915
PMCPMC4410065
OpenAlexW2075513455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.